Results to the Treatment of Burkitt's Lymphoma in Pediatric Patients of the University School Hospital during the period January 2005- December 2016

Abstract

Introduction.- Burkitt lymphoma is a highly aggressive non-Hodgkin's lymphoma and is the fastest growing human tumor. Its most common form of presentation is ganglion disease. Treatment is one of the great successes of oncology, following protocols led by societies of pediatric oncology.

Objective.- To determine the clinical and epidemiological characteristics of pediatric patients with Burkitt's lymphoma treated at the Hospital Escuela Universitario - Bloque Materno Infantil Hospital during the period January 2005- December 2016.

Methodology.- Descriptive study in pediatric patients with Burkitt's lymphoma, treated with the AHOPCA 2005 protocol in the Hemaoncology service of the Maternal and Child Hospital, non-probabilistic sampling for convenience. protocol reviewed by the Bioethics Committee / IHSS. The data collected were entered in the EPI-INFO statistical package.

Results.- The ages found were from 3 to 17 years old, 63.4% were men, with a male / female ratio of 1.9: 1. The most frequent clinical manifestations were palpable masses 87.8%, 19.5% were in stage I, 14.6% had a diagnosis of stage II, stage III were 51.3%, stage IV was found in 14.6% Complete remission of pathological process of 85.4 %, we had no relapses or initial tumor failures.

Conclusions.- Despite being a group of diseases with a high degree of malignancy, with high cell proliferation and therefore accelerated growth, the response to treatments is usually excellent due to the timely management of this condition in our healthcare center; achieving a high survival despite an underdeveloped country.